Literature DB >> 2004163

Amantadine for influenza A.

K G Nicholson, M J Wiselka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2004163      PMCID: PMC1669349          DOI: 10.1136/bmj.302.6774.425

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  19 in total

1.  Sensitivity of influenza A/New Jersey/8/76 (Hsw1N1) virus to amantadine-HCl.

Authors:  R R Grunert; C E Hoffmann
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

2.  Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

Authors:  W L Wingfield; D Pollack; R R Grunert
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

Review 3.  Antiviral activity of amantadine: a review of laboratory and clinical data.

Authors:  J S Oxford; A Galbraith
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

4.  Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.

Authors:  H Heider; B Adamczyk; H W Presber; C Schroeder; R Feldblum; M K Indulen
Journal:  Acta Virol       Date:  1981-11       Impact factor: 1.162

5.  A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis.

Authors:  Y J Bryson; C Monahan; M Pollack; W D Shields
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Therapeutic effects of aerosolized amantadine in naturally acquired infection due to influenza A virus.

Authors:  F G Hayden; W J Hall; R G Douglas
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

7.  Airway hyperreactivity and peripheral airway dysfunction in influenza A infection.

Authors:  J W Little; W J Hall; R G Douglas; G S Mudholkar; D M Speers; K Patel
Journal:  Am Rev Respir Dis       Date:  1978-08

8.  Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

Authors:  L P Van Voris; R F Betts; F G Hayden; W A Christmas; R G Douglas
Journal:  JAMA       Date:  1981-03-20       Impact factor: 56.272

9.  Plaque inhibition assay for drug susceptibility testing of influenza viruses.

Authors:  F G Hayden; K M Cote; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

10.  Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment.

Authors:  A W Galbraith; J S Oxford; G C Schild; G I Watson
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more
  10 in total

1.  Five years of sentinel surveillance of acute respiratory infections (1985-1990): the benefits of an influenza early warning system.

Authors:  R Snacken; J Lion; V Van Casteren; R Cornelis; F Yane; M Mombaerts; W Aelvoet; A Stroobant
Journal:  Eur J Epidemiol       Date:  1992-07       Impact factor: 8.082

2.  Amantadine for influenza A.

Authors:  M A Zuckerman; J S Oxford
Journal:  BMJ       Date:  1991-04-27

Review 3.  Influenza: diagnosis, management, and prophylaxis.

Authors:  M Wiselka
Journal:  BMJ       Date:  1994-05-21

4.  Influenza deaths in Leicestershire during the 1989-90 epidemic: implications for prevention.

Authors:  J S Nguyen-van-Tam; K G Nicholson
Journal:  Epidemiol Infect       Date:  1992-06       Impact factor: 2.451

Review 5.  Amantadine and rimantadine prophylaxis of influenza A in nursing homes. A tolerability perspective.

Authors:  D R Guay
Journal:  Drugs Aging       Date:  1994-07       Impact factor: 3.923

6.  Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study.

Authors:  K Krishnaprasad; P Manshani; J Karankumar
Journal:  Perspect Clin Res       Date:  2012-04

7.  Treatment Effectiveness of Amantadine Against Dengue Virus Infection.

Authors:  Chieh-Cheng Lin; Wen-Ching Chen
Journal:  Am J Case Rep       Date:  2016-12-05

Review 8.  Targeting viral entry as a strategy for broad-spectrum antivirals.

Authors:  Michela Mazzon; Mark Marsh
Journal:  F1000Res       Date:  2019-09-12

Review 9.  Current recommendations for the prevention and treatment of influenza in the older population.

Authors:  P A Gross
Journal:  Drugs Aging       Date:  1991 Nov-Dec       Impact factor: 3.923

Review 10.  Amantadine in treatment of chronic hepatitis C virus infection?

Authors:  J K Lim; D Wooten; R Siegel; R C Cheung
Journal:  J Viral Hepat       Date:  2005-09       Impact factor: 3.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.